Commentary

If workers in your company still are "flying solo," you may want to stimulate the innovative process by having them work in teams, according to columnist Tom Koulopoulos. In this edition of The Innovation Zone, Koulopoulos is reveling in the fact that he's become a...

The Japanese government has a strong commitment to its biotech industry, which has aided the second largest pharma market in the world. Yet Japanese Big Pharma doesn't seem to be paying a lot of attention to it, if the recent BIO-Japan conference is any indication,...

Many IT shops foolishly refer to “the customer” not only as the people who buy the company's products, but to people in other business units that need something from IT. In this edition of Breakthrough IT, columnist Patrick Gray says this distinction is counter-productive because...

Not unlike a vulture, an economic development organization in Kentucky is trying to swoop down and take full advantage of the specter of still higher taxation in Wisconsin, according to State Sen. Ted Kanavas. In this guest column for WTN, the Republican from Brookfield warns...

Can your early-stage business create so-called “strategic partnerships” to further develop business ideas? It's a common practice in technology and biotechnology businesses, but legal steps are needed to provide protection, notes columnist and attorney Joe Boucher. In this edtion of Early Stage, he spells out...

Separating innovation from invention is not rocket science, and there has been some evolution to distinguish the two, according to columnist Ogan Gurel. In this edition of MedTech Futures, Dr. Gurel points to historical proof from IBM that the best innovations are not necessarily about...

Who says Republicans and Democrats can't work together? Well, most people who pay close attention to politics say that, actually, but there are exceptions to the rule. In this edition of Inside Wisconsin, columnist Tom Still offers kudos to the Wisconsin congressional delegation for pulling...